Stevanato Group (NYSE:STVN) Issues FY 2025 Earnings Guidance

Stevanato Group (NYSE:STVN) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.544-0.587 for the period, compared to the consensus earnings per share estimate of 0.570. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Analyst Ratings Changes

STVN has been the subject of several research reports. Wolfe Research began coverage on shares of Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price objective for the company. Bank of America lifted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of €28.60 ($30.75).

Stevanato Group Stock Down 2.5 %

STVN opened at €18.84 ($20.26) on Thursday. The company has a 50 day moving average of €21.40 and a 200 day moving average of €20.51. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 12 month low of €16.56 ($17.81) and a 12 month high of €33.49 ($36.01). The company has a market cap of $5.71 billion, a PE ratio of 40.09, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. On average, sell-side analysts expect that Stevanato Group will post 0.5 EPS for the current year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.